Search Login Register

Epidermolytic Palmoplantar Keratoderma Summary

Description: An autosomal dominant hereditary skin disease characterized by epidermolytic hyperkeratosis that is strictly confined to the palms and soles. It has been associated with mutations in the gene that codes for KERATIN-9.

Also Known As: Keratoderma, Palmoplantar, Epidermolytic; EPPK (Epidermolytic Palmoplantar Keratoderma); Keratoderma, Epidermolytic Palmoplantar; Palmoplantar Keratoderma, Epidermolytic; Thost-Unna Disease, Epidermolytic Show All >>

Networked: 66 relevant articles (0 outcomes, 1 trials/studies) for this Disease

Key Drugs and Agents for Epidermolytic Palmoplantar Keratoderma

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Type I Keratins (Type I Keratin) : 1 study in 3 results : IBA
  2. Keratin-9 (Keratin 9) : 42 results : IBA
  3. Keratins (Keratin) : 13 results : IBA
  4. Keratin-1 : 4 results : IBA
  5. Type II Keratins (Type II Keratin) : 2 results : IBA
  6. RNA Splice Sites : 1 result : IBA
  7. Leucine (L-Leucine) : 1 result : FDA 31
  8. Etretinate : 1 result : FDA 1
  9. Hyperkeratosis of the palms and soles and esophageal papillomas : 1 result : IBA
  10. Mal de Meleda : 1 result : IBA
Show All >>

Diseases Related to Epidermolytic Palmoplantar Keratoderma

  1. Palmoplantar Keratoderma (Keratosis Palmaris et Plantaris)
  2. Epidermolytic Hyperkeratosis (Bullous Congenital Ichthyosiform Erythroderma)
  3. Pachyonychia Congenita (Jadassohn-Lewandowsky Syndrome)
  4. Ichthyosis Bullosa of Siemens
  5. Monilethrix
Show All >>

Key Therapies for Epidermolytic Palmoplantar Keratoderma

Efficacy Chart >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.